Back to discover
Disease

Ureteral Neoplasms

Active therapeutic pipelineEmerging research
1
Publications
6
Clinical trials
2009
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Executive briefingUpdating summary…Momentum: Low
Key developments
  • 1 clinical trial expected to report results, the earliest in Q2 2027.

Clinical trials

6 sponsors · 0 new · 0 completed in the last 12 months (net -1)

The current development programme across all trial phases.

Research activity

1 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Major themes1
  • Nephrectomy1
Leading journals1
  • Cancer1
Leading researchers8
  • Kamat AM1
  • Kikuchi E1
  • Lotan Y1
  • Margulis V1
  • Matin SF1
  • Raman JD1
  • Shariat SF1
  • Weizer A1
Affiliations (unnormalised)1
  • The University of Texas M.D. Anderson Cancer Center1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Cancer or tumors of the URETER which may cause obstruction leading to hydroureter, HYDRONEPHROSIS, and PYELONEPHRITIS. HEMATURIA is a common symptom.

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.